AqVida partners with cleanrooms leader MRC to offer hi-tech manufacturing solutions
Press Release | AqVida GmbH
MARCH 31, 2016
Hamburg, Germany: – Innovative north German oncology manufacturer AqVida has partnered with UK-based cleanrooms specialist MRC.
The partnership will offer total solutions based on MRC’s world-leading GRP cleanroom paneling systems, combined with AqVida’s highly advanced production and process expertise. It will include modular construction solutions enhanced by implementation support and consultancy optimized to Pharma and Biopharma applications.
Rollout in Stuttgart: Pharma Lounges 2016
The service will be rolled out when MRC attends the ‘Pharma Lounges’ on Cleanroom and Pharmaceutical Process Technology in Stuttgart on 5th of April – 07th of April, where AqVida founder and CEO, Wolfgang Heinze, will join the MRC team at Booth G1.4.
“Our shared vision of premium quality, innovation and reliability mean MRC and AqVida have created a formidable partnership to supply German based pharmaceutical manufacturing facilities with the MRC GRP cleanroom paneling system, along with local installation and support,” said Mr. Heinze.
The partnership was born from AqVida’s choice of MRC technologically advanced panel systems to fit out the advanced production areas at its new highly automated Dassow oncology drugs and ADC manufacturing facility.
“As part of our uncompromising approach on redefining state of the art in injectable drug manufacturing at Dassow, we chose MRC as the world’s leading developers of premium cleanroom panels. The extraordinary quality of these panels is a perfect fit for a facility which is ultra-modern and fulfills AqVida´s expectations on product and patient safety,” said Mr. Heinze.
Optimized cleanroom design
“It was the only cleanroom panel we found that could be repaired in situ, which is extremely resistant and allowed us to optimize every single detail in our design. We are extremely happy to cooperate with MRC going forward,” he added.
The AqVida Dassow plant is on schedule to begin operations at the end of 2016, introducing highly advanced robotic and isolator-based ‘zero loss’ aseptic filling technologies that represent a breakthrough for the oncology and biotech sectors.
AqVida is using latest techniques for designing equipment and processes to support product and patient safety. These include coordinated process optimization and comprehensive control technologies along with a refrigeration system optimized to correspond with technical loads.
AqVida GmbH is a German pharmaceutical company specializing in the fast-track development registration and distribution of finished dosage forms mainly in the oncology sector. It has developed a portfolio of medicines for treating the most common types of cancer.
AqVida’s expertise in the development, registration and supply of generic oncology products and biosimilars has made the company a leading partner in the pharmaceutical industry. The Hamburg-based company also has offices in Oberhaching, Bavaria and in Hangzhou, China.
AqVida works alongside some of the major companies in the market of oncology products. Together with its partners AqVida has achieved substantial development and growth with its oncology portfolio.
After having developed and launched several oncology parenteral forms such as e.g. Paclitaxel, Docetaxel and Oxaliplatin, AqVida and its partner company, Benavis, have started development work on the ‘tinib’ series of molecular targeted anti-cancer molecules. AqVida is also developing other molecular targeted anti-cancer molecules, such as Sunitinib.
Products are sold under the AqVida brand or those of its partners’ in the EU and other markets.
AqVida has an impressive track record in oncology, obtaining some 150 approvals for its products in several countries over the past few years. Well-established manufacturing and supply-chain have been established as part of AqVida’s leading presence in the high-quality German oncology market.
AqVida’s “Quality is Core” policy and very stringent drug safety expectations applies to all new product development, which are all carried out in-house.
MRC is a British founded company offering uniquec cleanroom products and turnkey solutions to international clients from offices and sales agents around the world. Over 35 years, MRC has developed products driven by its corporate vision; to help its clients innovate, improve and grow.
It developed the MRC GRP cleanroom paneling system specifically to solve environmental, management and maintenance issues shared between pharmaceuticals, aerospace, micro-electronics, healthcare, renewable energy, military and other high-end engineering industries.
Purpose designed by cleanroom experts, for cleanroom applications, MRC’s renowned GRP panelling system has redefined the state-of-the-art for advanced cleanroom surface systems. The panels’ unique GRP formulation and specification provide an impervious smooth surface that is inherently strong, resistant to damage and chemical attack without relying on thin surface coating to provide the required cleanroom surface finish. The panel system enables the designer and user to achieve ideal airflow movements while allowing flexibility in provision of service points. Modular construction promotes layout flexibility; re-usability; speed of construction and cost-effectiveness. It also avoids the maintenance problems often associated with metallic and phenolic cleanroom panel alternatives.
To ensure offerings that are precisely adapted to purpose, MRC’s design and implementation is closely aligned with specific manufacturing and process requirements for individual clients, offering controlled environment solutions from design phase through to fabrication, installation, validation and commissioning.
About LOUNGES 2016
The Pharma LOUNGES series of events provides a new, innovative and pioneering networking platform, merging the concept of a trade fair with the objectives of a presentation event. Each lounge event provides a distinctive ambience and future-oriented format, presenting innovative products and topics in a special framework, with exhibitor booths formatted as salons.
The LOUNGES format focuses on the exchange of information between visitors and exhibitors during discussions at the booths, during presentations and in discussion forums.
LOUNGES 2016 on Cleanroom and Pharmaceutical Process Technology is a three-day event opening April 5 at Messe, Stuttgart. It will combine a high level presentation programme with a series of simultaneous sessions, providing information and debate on current themes, uniting research, technology and operations.
More information at: http://www.expo-lounges.de/en/home.html
Jürgen Lehmberg, Commercial Director, AqVida GmbH
Wolfgang Heinze, CEO, AqVida GmbH
Tel: +49 40 380 37190
Click on AqVida partners with cleanrooms leader MRC to offer hi-tech manufacturing solutions for other information.
Click on AqVida to contact the company directly.